This company listing is no longer active
Hamilton Thorne (HTL) Stock Overview
Develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for HTL from our risk checks.
HTL Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Hamilton Thorne Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$2.24 |
| 52 Week High | CA$2.25 |
| 52 Week Low | CA$1.17 |
| Beta | 0.41 |
| 1 Month Change | 0.45% |
| 3 Month Change | 4.67% |
| 1 Year Change | 85.12% |
| 3 Year Change | 6.67% |
| 5 Year Change | 111.32% |
| Change since IPO | 489.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| HTL | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | 0% | 2.5% | -1.0% |
| 1Y | 85.1% | -10.8% | 28.9% |
Return vs Industry: HTL exceeded the Canadian Medical Equipment industry which returned -17.8% over the past year.
Return vs Market: HTL exceeded the Canadian Market which returned 22.2% over the past year.
Price Volatility
| HTL volatility | |
|---|---|
| HTL Average Weekly Movement | 1.6% |
| Medical Equipment Industry Average Movement | 15.2% |
| Market Average Movement | 9.7% |
| 10% most volatile stocks in CA Market | 16.6% |
| 10% least volatile stocks in CA Market | 3.7% |
Stable Share Price: HTL has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: HTL's weekly volatility has decreased from 8% to 2% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Kate Torchilin | www.hamiltonthorne.ltd |
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.
Hamilton Thorne Ltd. Fundamentals Summary
| HTL fundamental statistics | |
|---|---|
| Market cap | CA$345.34m |
| Earnings (TTM) | -CA$2.93m |
| Revenue (TTM) | CA$106.84m |
Is HTL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HTL income statement (TTM) | |
|---|---|
| Revenue | US$76.30m |
| Cost of Revenue | US$37.45m |
| Gross Profit | US$38.85m |
| Other Expenses | US$40.94m |
| Earnings | -US$2.09m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.014 |
| Gross Margin | 50.92% |
| Net Profit Margin | -2.74% |
| Debt/Equity Ratio | 29.9% |
How did HTL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/29 20:07 |
| End of Day Share Price | 2024/11/29 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hamilton Thorne Ltd. is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jim Byrne | Acumen Capital Finance Partners Limited |
| Kyle McPhee | ATB Cormark Historical (Cormark Securities) |
| Doug Cooper | Beacon Securities Limited |